Status:
RECRUITING
REspiratory diSEAse cohoRt Studies of CHinese Medicine for ILD (RESEARCH-ILD)
Lead Sponsor:
Henan University of Traditional Chinese Medicine
Conditions:
Interstitial Lung Disease
Eligibility:
All Genders
18+ years
Brief Summary
This study is a traditional Chinese medicine cohort for interstitial lung disease（ILD） in China, including at least 5000 patients with ILD and followed up for at least 5 years. The aim is to focus on ...
Detailed Description
This study focuses on ILD patients and adopts a prospective cohort study design, with traditional Chinese medicine treatment as the exposure factor. The subjects are divided into a traditional Chinese...
Eligibility Criteria
Inclusion
- Patients who meet the diagnosis of ILD;
- Age≥18 years old;
- Ability to provide independent informed consent.
Exclusion
- Patients with acute ILD caused by known reasons, but the lesions disappear within 2 weeks after treatment. Example: Interstitial pneumonia caused by infections such as mycoplasma/virus, and those who recover after treatment are excluded.
Key Trial Info
Start Date :
April 15 2024
Trial Type :
OBSERVATIONAL
Allocation :
ESTIMATED
End Date :
December 30 2030
Estimated Enrollment :
5000 Patients enrolled
Trial Details
Trial ID
NCT06577753
Start Date
April 15 2024
End Date
December 30 2030
Last Update
August 29 2024
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
The First Affiliated Hospital of Henan University of Chinese Medicine
Zhengzhou, Henan, China